* Rockwell Medical Inc reported quarterly adjusted earnings of 5 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -7 cents. The mean expectation of two analysts for the quarter was for earnings of one cent per share.
* Revenue rose 19.1% to $28.32 million from a year ago; analysts expected $26.50 million.
* Rockwell Medical Inc's reported EPS for the quarter was 5 cents.
* The company reported quarterly net income of $1.66 million.
* Rockwell Medical Inc shares had risen by 17.1% this quarter and gained 146.0% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the pharmaceuticals peer group is also "buy"
Wall Street's median 12-month price target for Rockwell Medical Inc is 7.50 This summary was machine generated from LSEG data November 12 at 01:38 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.01 0.05 Beat
Jun. 30 2024 -0.03 0.01 Beat
Mar. 31 2024 -0.04 -0.06 Missed
Dec. 31 2023 -0.07 -0.05 Beat
Comments